Role of Insulin Resistance in MAFLD.

Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. · 2021

Read Role of Insulin Resistance in MAFLD. by Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8072900.txt.

Description

Sakurai and co-authors explain the role of insulin resistance in fatty liver disease tied to metabolic dysfunction. The field is renaming the condition MAFLD to match its true drivers. Those drivers span obesity, type 2 diabetes, high blood pressure, and skewed blood lipids. Insulin resistance sits beneath them all as common ground. A global estimate puts the older-named disease at 24% of people.

When energy intake outruns spending, tissues stop answering insulin well. Fat then piles into the liver, and gut microbes shift too. Liver insulin resistance pours fuel on the fire. It drives fresh fat making inside the liver itself. Damage, inflammation, scarring, and even cancer can follow. Genes shape how fast each stage arrives. The review maps local and body-wide resistance together. It ends with the stress signals that lock the process in.

Catalog record

CREATORSakurai Y, Kubota N, Yamauchi T, Kadowaki T.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE99 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8072900

Browse the full library · About the Tower of Babel